CNR1 and Alzheimer disease: Crunfli et al. [52] investigated the effects of arachidonyl-2’-chloroethylamide (ACEA), a CB1R agonist, in neuro-2a neuroblastoma cells and streptozotocin (STZ)-induced AD models.